Mitsui Chemicals, Inc. · TSE:4183

Mitsui Chemicals — Q1 FY2023 Earnings Presentation

36 slides from Mitsui Chemicals's earnings presentation, Aug 4, 2023

  1. Slide 1: Financial Summary: Results for 1st Quarter of FY2023 & Outlook for FY2023

    Financial Summary Results for 1st Quarter of FY2023 & Outlook for FY2023 Mitsui Chemicals, Inc. ＜Remarks＞ Aug 4, 2023 FY2023 indicates the period from April 1, 2023 to March 31, 2024. This summary contains forward-looking statements about the future plans, strategies, belief and performance of the M

  2. Slide 2: Contents

    Contents 1. Results for 1st Quarter of FY2023 (April 1, 2023 – June 30, 2023) 1) Trends of Key Market Indicators ･･･ 1 2) Major Investment Projects, etc. ･･･ 2 3) Consolidated Financial Highlights ･･･ 3-4 4) Sales Revenue and Operating Income before Special Items by Business Segment ･･･ 5 (compared

  3. Slide 3: 1. Results for 1st Quarter of FY2023

    1. Results for 1st Quarter of FY2023 (April 1, 2023 – June 30, 2023) Copyright © 2023 Mitsui Chemicals, Inc.

  4. Slide 4: 1) Trends of Key Market Indicators

    1) Trends of Key Market Indicators FY2023 FY2023 1H→ (changes from 1Q 2Q 2H ２H previous outlook) Firm demand Firm demand to continue Firm demand to continue Demand staying Life ＆ Ophthalmic lens materials market (Movements to adjust inventory (Inventory adjustments to (Inventory adjustments to firm;

  5. Slide 5: 2) Major Investment Projects, etc.

    2) Major Investment Projects, etc. Major Investment projects Date Capacity FY21 FY22 FY23 FY24~ Orthopedic surgery sector: Japan MDM Business and Capital Alliance January.'22 - Life & Acquisition of agrochemicals business January.'22 - Healthcare Acquisition of ophthalmic lens processing equipment m

  6. Slide 6: 3-1) Consolidated Financial Highlights

    3-1) Consolidated Financial Highlights (Billions of Yen) () Denotes a minus FY2022 FY2023 Increase Items % 1Q 1Q (Decrease) Sales revenue 476.1 407.9 (68.2) (14%) Operating income before special 44.6 20.9 (23.7) (53%) items (inc. Equity in earnings) 9.0 3.2 (5.8) (64%) Non-recurring items (1.7) (7.0

  7. Slide 7: 3-2) Consolidated Financial Highlights (Operating Income before Special Items)

    3-2) Consolidated Financial Highlights (Operating Income before Special Items) Profit/loss Factors Comments trigger ・Vision care materials decreased due to movements to adjust inventory levels in some markets. ［-］ ・Automotive applications increased driven by recovery in automotive production. ［+］ Vo

  8. Slide 8: 4) Sales Revenue and Operating Income before Special Items by Business Segment

    4) Sales Revenue and Operating Income before Special Items by Business Segment (compared with corresponding period of FY2022 results) (Billions of Yen) () Denotes a minus Operating income before special Sales revenue Breakdown items Segment FY2022 FY2023 Incr. FY2022 FY2023 Incr. Terms of Volume Cos

  9. Slide 9: 5-1) Life & Healthcare Solutions: Operating Income and Business Overview

    5-1) Life & Healthcare Solutions: Operating Income before Special Items and Business Overview Comments Business Overview of FY23.1Q [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger ・Sales were down due to movements to adjust inventory levels in so

  10. Slide 10: 5-2) Mobility Solutions: Operating Income and Business Overview

    5-2) Mobility Solutions: Operating Income before Special Items and Business Overview Comments Business Overview of FY23.1Q [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger ・Sales of solar cell encapsulants remained firm [+]Terms of trade Elastomer

  11. Slide 11: 5-3) ICT Solutions: Operating Income and Business Overview

    5-3) ICT Solutions: Operating Income before Special Items and Business Overview Comments Business Overview of FY23.1Q [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger ・Sales were down, with sluggish demand in semiconductor and smartphone markets m

  12. Slide 12: 5-4) Basic & Green Materials: Operating Income and Business Overview

    5-4) Basic & Green Materials: Operating Income before Special Items and Business Overview Comments Business Overview of FY23.1Q [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger ・Sales were down due to weaker demand [-]Sales volume ・Terms of trade

  13. Slide 13: 6) Non-recurring Items

    6) Non-recurring Items (Billions of Yen) () Denotes a minus FY2022 FY2023 Incr. Items 1Q 1Q (Decr.) Loss (gain) on sales and disposal of non-current assets (0.2) 0.0 0.2 Impairment loss (1.6) (9.2) (7.6) Others 0.1 2.2 2.1 Non-recurring items total (1.7) (7.0) (5.3) 1. Results for 1st Quarter of FY2

  14. Slide 14: 7) Consolidated Statement of Financial Position

    7) Consolidated Statement of Financial Position (Billions of Yen) () Denotes a minus End of End of Incr. End of End of Incr. Items Items Mar.2023 Jun.2023 (Decr.) Mar.2023 Jun.2023 (Decr.) Current assets 1,094.3 1,078.9 (15.4) Liabilities 1,184.9 1,155.2 (29.7) Cash and cash equivalents 186.3 169.0

  15. Slide 15: 8) Consolidated Statement of Cash Flow

    8) Consolidated Statement of Cash Flow (Billions of Yen) () Denotes a minus FY2022 FY2023 Incr. Items 1Q 1Q (Decr.) Ⅰ．Cash flows from operating activities (a) (10.6) (11.7) (1.1) Ⅱ．Cash flows from investing activities (b) (33.3) 9.9 43.2 Free cash flows (a)+(b) (43.9) (1.8) 42.1 Ⅲ．Cash flows from fi

  16. Slide 16: 2. Outlook for FY2023

    2. Outlook for FY2023 (April 1, 2023 – March 31, 2024) Mitsui Chemicals, Inc. has changed its business segment structure effective April 1, 2022. Results for FY2021 and prior years based on the new business segments are reference figures which have been prepared for the purpose of comparison with fi

  17. Slide 17: 1-1) Highlights of Consolidated Financial Outlook

    1-1) Highlights of Consolidated Financial Outlook (Billions of Yen) () Denotes a minus FY2023 FY2023 FY2022 Incr.(Decr.) Previous Outlook Outlook Items (on May 12,2023) 1st Half Full Year 1st Half Full Year Full Year ％ Full Year Sales revenue 951.1 1,879.5 870.0 1,850.0 (29.5) (2%) 1,900.0 Operating

  18. Slide 18: 1-2) Highlights of Consolidated Financial Outlook by Business Segment

    1-2) Highlights of Consolidated Financial Outlook Operating Income before Special Items of Outlook by Business Segment (compared with previous outlook for FY2023) (Billions of Yen) () Denotes a minus Operating income before special items FY2023 Comments Segment Previous [+] denotes profit trigger Ou

  19. Slide 19: 1-3) Highlights of Consolidated Financial Outlook (Operating Income before Special Items)

    1-3) Highlights of Consolidated Financial Outlook (Operating Income before Special Items) Profit/loss Factors Comments trigger ・Sales for vision care materials and agrochemicals expected to remain firm. ［+］ ・Automotive applications expected to recover; solar cell encapsulants expected to remain firm

  20. Slide 20: 2-1) Life & Healthcare Solutions: Outlook and Business Overview

    2-1) Life & Healthcare Solutions: Operating Income before Special Items and Business Overview Comments Business Overview of FY23 (Outlook): [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger ・Sales expected to be firm in FY23 2Q and onward [+]Sales

  21. Slide 21: 2-2) Mobility Solutions: Outlook and Business Overview

    2-2) Mobility Solutions: Operating Income before Special Items and Business Overview Comments Business Overview of FY23 (Outlook): [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger ・Sales increase driven by recovery in automotive applications and f

  22. Slide 22: 2-3) ICT Solutions: Outlook and Business Overview

    2-3) ICT Solutions: Operating Income before Special Items and Business Overview Comments Business Overview of FY23 (Outlook): [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger ・EUV pellicle sales expected to remain firm; sales increase from acquisi

  23. Slide 23: 2-4) Basic & Green Materials: Outlook and Business Overview

    2-4) Basic & Green Materials: Operating Income before Special Items and Business Overview Comments Business Overview of FY23 (Outlook): [+] denotes profit trigger Movement of Operating Income before Special Items [-] denotes loss trigger ・Sales volume expected to increase due to demand recovery in F

  24. Slide 24: 3) Operating Income of Outlook by Business Segment (2Q vs. 1Q)

    3) Operating Income before Special Items of Outlook by Business Segment (2Q vs. 1Q of FY2023) (Billions of Yen) () Denotes a minus Operating income before special items FY2023 Comments Segment 2Q Incr. [+] denotes profit trigger 1Q [-] denotes loss trigger Outlook (Decr.) Life & Healthcare 4.5 11.0

  25. Slide 25: 4) Operating Income of Outlook by Business Segment (2H vs. 1H)

    4) Operating Income before Special Items of Outlook by Business Segment (2H vs. 1H of FY2023) (Billions of Yen) () Denotes a minus Operating income before special items FY2023 Comments Segment 1H 2H Incr. [+] denotes profit trigger [-] denotes loss trigger Outlook Outlook (Decr.) Life & Healthcare [

  26. Slide 26: 5) Consolidated Statement of Cash Flow (Outlook)

    5) Consolidated Statement of Cash Flow (Outlook) (Billions of Yen) () Denotes a minus FY2023 FY2023 FY2022 Previous Outlook Outlook Incr.(Decr.) (on May 12,2023) Items (b)-(a) 1st Half Full Year(a) 1st Half Full Year(b) Full Year Ⅰ．Cash flows from operating activities (a) 21.9 101.2 56.0 141.0 39.8

  27. Slide 27: 3. Appendix

    3. Appendix 1) Performance Trends by Business Segment 2) Trends in Product Prices 3) Sales Revenue Increase/Decrease (Year on Year) by Business Segment 4) Sales Revenue and Operating Income before Special Items by Business Segment 5) Outline of Business Segments 6) Data Highlights Copyright © 2023 M

  28. Slide 28: 1) Performance Trends by Business Segment

    1) Performance Trends by Business Segment 200.0 188 40.0 161.8 125.0 47.0 113.9 138 Basic & Green 77.8 10.0 Materials 17.8 28.0 ICT Solutions 85.1 23.8 60.0 88 72.3 9.0 19.9 30.2 Mobility 57.0 17.4 Solutions 25.3 49.3 38 33.2 35.6 17.8 Life & 65.0 36.0 Healthcare 23.1 24.9 29.2 Solutions 14.8 Others

  29. Slide 29: 2) Trends in Product Prices

    2) Trends in Product Prices (Naphtha prices are Domestic Standard Naphtha Price ) (PE, PP, PH, BPA(Japan) : Change in Prices and Raw Materials Prices in Japan / BPA(China), PTA, TDI : Chinese Market Price) (ACP) : Asian contract price Year 2020 2021 2022 2023 Month Jul.-Sep. Oct.-Dec. Jan.-Mar. Apr.

  30. Slide 30: 3-1) Sales Revenue Increase/Decrease by Business Segment

    3-1) Sales Revenue Increase/Decrease (Year on Year) by Business Segment Life & Healthcare （Unit:Billions of yen） () Denotes a minus 売上高 ➢ Volume (4.5) billion yen - Sales of vision care materials and nonwovens decreased. (1.6) ➢ Prices +2.9 billion yen （Unit:Billions of yen） Mobility 売上高 ➢ Volume +3

  31. Slide 31: 3-2) Sales Revenue Increase/Decrease by Business Segment

    3-2) Sales Revenue Increase/Decrease (Year on Year) by Business Segment ICT （Unit:Billions of yen） () Denotes a minus 売上高 ➢ Volume (6.5) billion yen - Sales of semiconductor and smart phone applications decreased. (2.3) ➢ Prices +4.2 billion yen - Foreign exchange impact, etc. Basic & Green （Unit:Bi

  32. Slide 32: 4) Sales Revenue and Operating Income before Special Items by Business Segment

    4) Sales Revenue and Operating Income before Special Items by Business Segment (Billions of Yen) () Denotes a minus Sales revenue Segment FY2022 FY2023 Jul-Sep 2H Apr-Jun Jul-Sep Oct-Dec Jan-Mar Apr-Jun Outlook Outlook Life & Healthcare Solutions 58.7 63.4 64.7 71.4 57.1 71.9 159.0 Mobility Solution

  33. Slide 33: 5) Outline of Business Segments

    5) Outline of Business Segments Segment Businesses Main Products Vision Care Materials, Ophthalmic lens materials (MR™, Do Green™), Personal Care Materials, Medical materials (taurine), Life & Healthcare Nonwovens, Oral Care, Nonwovens (SYNTEX™, AIRYFA™, TEKNOROTE™), Solutions Agrochemicals and Medi

  34. Slide 34: 6-1) Data Highlights

    6-1) Data Highlights () Denotes a minus ～FY19：J-GAAP / FY20～：IFRS （Billions of Yen） Total Assets （Billions of Yen） 2,500 Net Sales/Sales Revenue 2,200 2,068.2 2,000 1,935.0 1,879.5 1,850.0 2,000 1,612.7 1,800 1,482.9 *1 1,500 1,328.5 1,339.0 1,211.7 1,558.1 1,212.3 1,600 1,501.1 1,480.1 1,431.3 1,00

  35. Slide 35: 6-2) Data Highlights

    6-2) Data Highlights ～FY19：J-GAAP / FY20～：IFRS （Billions of Yen） 250.0 Capital Expenditure （Billions of Yen） Depreciation & Amortization 207.1 185.0 120.0 200.0 168.0 *3 92.1 98.0 100.0 84.2 150.0 76.6 *1 *2 80.0 93.2 52.1 100.0 81.2 61.9 76.3 60.0 44.1 45.7 49.5 45.4 40.0 50.0 20.0 0.0 0.0 '16 '17

  36. Slide 36: Chemistry for Sustainable World

    Chemistry for Sustainable World Challenge Diversity One Team Copyright © 2023 Mitsui Chemicals, Inc.

Mitsui Chemicals — Q1 FY2023 Earnings Presentation on 6ix